<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:41:51.264118+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-VEN-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">HIV and TB prevention and care for key population in Venezuela. - Venezuela (Bolivarian Republic) (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Venezuela (Bolivarian Republic), TB/HIV, United Nations Development Programme (UNDP Venezuela)This program has the following goals: Reducir los nuevos casos de VIH, con enfoque en las poblaciones clave/Reducing new HIV cases, focusing on key populations..  Ampliar la cobertura y calidad del tratamiento antirretroviral, con énfasis en las poblaciones clave para el VIH/ Expand coverage and quality of antiretroviral treatment, with emphasis on key populations for HIV..  Reducir de la carga de tuberculosis en todas sus formas entre las poblaciones vulnerables/ Reducing the burden of tuberculosis in all its forms among vulnerable populations..  Asegurar la prevención, el abordaje y el tratamiento de la coinfección TB/VIH/ Ensure prevention, management and treatment of TB/HIV coinfection.. The objectives of this program are: Facilitar el acceso de las poblaciones clave a los servicios de prevención y diagnóstico de VIH con participación comunitaria / Facilitate access of key populations to HIV prevention and diagnostic services with community participation..  Asegurar el tratamiento antirretroviral continuado para todas las personas que lo necesiten, con énfasis en las poblaciones clave y en participación con la comunidad / Ensure continued antiretroviral treatment for all people in need, with emphasis on key populations and in partnership with the community..  Reducir el estigma y la discriminación asociados al VIH y a las poblaciones clave, especialmente en los servicios de salud / Reduce stigma and discrimination associated with HIV and key populations, especially in health services..  Fortalecer la vinculación de las poblaciones clave a servicios de atención de calidad para el VIH/Strengthen linkage of key populations to quality HIV care services..  Fortalecer la oferta de servicios de prevención, diagnóstico y tratamiento de la tuberculosis en todas sus formas para las poblaciones vulnerables / Strengthen linkage of key populations to quality HIV care services..  Asegurar el diagnóstico y la atención de calidad para las personas con TB-RR/MDR / Ensuring quality diagnosis and care for people with MDR/RR-TB.  Implementar las actividades colaborativas entre los programas de VIH y de tuberculosis / Implement collaborative activities between HIV and tuberculosis programs.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="VEN-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Cecilia, VITALE</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>cecilia.vitale@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="VE" percentage="100">
			<narrative xml:lang="en">Venezuela (Bolivarian Republic)</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="66">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="15">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="3">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="16">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="41">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="15">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">4448735.55</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">4535333.06</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-01-01">10672862.46</value>
		</budget>
		<transaction ref="73a2f327-c882-4fa4-acc5-3a85a45c0cf7">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-24" />
			<value currency="USD" value-date="2026-01-24">3687751.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cd677ffa-5487-433f-bfae-ffca7f343c9c">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-24" />
			<value currency="USD" value-date="2026-01-24">-915250.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2dfbe4c2-79f5-4623-ab29-7ca84afc66b5">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-10-09" />
			<value currency="USD" value-date="2025-10-09">5498239.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e0a99530-3687-41bb-b753-d0ade7ae49fe">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-14" />
			<value currency="USD" value-date="2023-12-14">9843940.50</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="da01f1ce-e6a9-4629-a3f3-263e6fbc5627">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-17" />
			<value currency="USD" value-date="2024-12-17">2842779.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e1e223a5-5eb4-40e8-8381-a79da141e265">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-10-14" />
			<value currency="USD" value-date="2025-10-14">4582989.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c82f1fe9-7f1f-48cf-babb-3b72c446d80a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-19" />
			<value currency="USD" value-date="2023-12-19">5523476.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c16f0b44-6a56-4710-a58a-023ae76faa98">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-01-27" />
			<value currency="USD" value-date="2026-01-27">3687751.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="12a26347-6f3e-4862-8edd-7f8c05ef8263">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-09-12" />
			<value currency="USD" value-date="2024-09-12">1477685.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to VEN-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Venezuela)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/VEN-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for VEN-C-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="5564" />
					<actual value="5316" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="67.87" />
					<actual value="74.74" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="1030" />
					<actual value="528" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="85.00" />
					<actual value="77.86" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="35.13" />
					<actual value="28.98" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="0.65" />
					<actual value="0.43" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="12.01" />
					<actual value="44.54" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="95.00" />
					<actual value="57.96" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="75" />
					<actual value="58" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="100.00" />
					<actual value="98.28" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>